These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Canadian Contraception Consensus (Part 2 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [TBL] [Abstract][Full Text] [Related]
3. Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada? Patel S; Kostaras X; Parliament M; Olivotto IA; Nordal R; Aronyk K; Hagen N Curr Oncol; 2014 Oct; 21(5):251-62. PubMed ID: 25302033 [TBL] [Abstract][Full Text] [Related]
4. Canadian Contraception Consensus (Part 1 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N; J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712 [TBL] [Abstract][Full Text] [Related]
5. Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada. Marshall DA; Douglas PR; Drummond MF; Torrance GW; Macleod S; Manti O; Cheruvu L; Corvari R Pharmacoeconomics; 2008; 26(6):477-95. PubMed ID: 18489199 [TBL] [Abstract][Full Text] [Related]
6. Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109 [TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
9. What Conditions Make Proton Beam Therapy Financially Viable in Western Canada? Smith WL; Smith CD; Patel S; Eisenstat DD; Quirk S; Mackenzie M; Olivotto IA Cureus; 2018 Nov; 10(11):e3644. PubMed ID: 30723643 [TBL] [Abstract][Full Text] [Related]
10. Developing recommendations for the safe handling of oral anti-cancer drugs in community pharmacies: A pan-Canadian consensus approach. Vu K; Emberley P; Brown E; Abbott R; Bates J; Bourrier V; Djordjevic K; Greenall J; Leung M; Pasetka M; Paquet L; Logan H J Oncol Pharm Pract; 2019 Apr; 25(3):674-688. PubMed ID: 30200843 [TBL] [Abstract][Full Text] [Related]
11. Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations. Binder L; Ghadban M; Sit C; Barnard K Curr Oncol; 2022 Mar; 29(3):1514-1526. PubMed ID: 35323327 [TBL] [Abstract][Full Text] [Related]
12. Choosing Wisely Canada cancer list: ten low-value or harmful practices that should be avoided in cancer care. Mitera G; Earle C; Latosinsky S; Booth C; Bezjak A; Desbiens C; Delouya G; Laing K; Camuso N; Porter G J Oncol Pract; 2015 May; 11(3):e296-303. PubMed ID: 25980018 [TBL] [Abstract][Full Text] [Related]
13. Hadrontherapy for cancer. An overview of HTA reports and ongoing studies. Jefferson T; Formoso G; Venturelli F; Vicentini M; Chiarolla E; Ballini L Recenti Prog Med; 2019 Dec; 110(12):566-586. PubMed ID: 31909760 [TBL] [Abstract][Full Text] [Related]
14. Vascular Access Practice Patterns in Canada: A National Survey. Dumaine C; Kiaii M; Miller L; Moist L; Oliver MJ; Lok CE; Hiremath S; MacRae JM Can J Kidney Health Dis; 2018; 5():2054358118759675. PubMed ID: 29511569 [TBL] [Abstract][Full Text] [Related]
15. HTA decision-making for drugs for rare diseases: comparison of processes across countries. Stafinski T; Glennie J; Young A; Menon D Orphanet J Rare Dis; 2022 Jul; 17(1):258. PubMed ID: 35804398 [TBL] [Abstract][Full Text] [Related]
16. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support. International Liaison Committee on Resuscitation Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790 [TBL] [Abstract][Full Text] [Related]
17. Defining Clinical Indications of Proton Beam Therapy at National Level in the Kingdom of Saudi Arabia. AlHussain H; Balbaid A; Malyapa R; AlOthman M; Bahadur YA; Tunio MA; Al Asiri M Saudi Med J; 2019 Sep; 40(9):879-886. PubMed ID: 31522214 [TBL] [Abstract][Full Text] [Related]
18. Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement. Sehdev SR; Rawson NSB; Aseyev OI; Buick CJ; Butler MO; Edwards S; Gill S; Gotfrit JM; Hsia CC; Juergens RA; Manna M; McCarthy JS; Mukherjee SD; Snow SL; Spadafora S; Stewart DJ; Wentzell JR; Wong RPW; Zalewski PG Curr Oncol; 2024 Mar; 31(4):1803-1816. PubMed ID: 38668039 [TBL] [Abstract][Full Text] [Related]